Corsair Capital Management, L.P. Enzo Biochem Inc Transaction History

Corsair Capital Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.84 - $2.66 $12,438 - $17,981	-6,760 Reduced 12.41%	47,726 $87,000
Q1 2023 May 12, 2023	SELL	$1.0 - $2.51 $12,115 - $30,408	-12,115 Reduced 18.19%	54,486 $132,000
Q4 2022 Feb 13, 2023	SELL	$1.16 - $2.42 $9,799 - $20,444	-8,448 Reduced 11.26%	66,601 $95,000
Q3 2022 Nov 14, 2022	BUY	$2.1 - $2.73 $48 - $62	23 Added 0.03%	75,049 $167,000
Q1 2022 May 13, 2022	BUY	$2.9 - $3.47 $47,470 - $56,800	16,369 Added 27.91%	75,026 $218,000
Q4 2021 Feb 14, 2022	BUY	$3.17 - $4.09 $185,942 - $239,907	58,657 New	58,657 $188,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $3.77 $50,902 - $63,754	-16,911 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.86 - $3.61 $48,365 - $61,048	16,911 New	16,911 $54,000
Q1 2021 May 14, 2021	SELL	$2.61 - $4.08 $303,412 - $474,300	-116,250 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.82 - $2.61 $175,668 - $251,919	96,521 Added 489.23%	116,250 $293,000
Q3 2020 Nov 13, 2020	BUY	$2.02 - $3.02 $39,852 - $59,581	19,729 New	19,729 $42,000
Q3 2017 Nov 13, 2017	SELL	$10.45 - $11.44 $518,988 - $568,156	-49,664 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	49,664	49,664 $548,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Corsair Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Corsair Capital Management, L.P. with notifications on news.